Hims & Hers Health said on Feb 19 that it will acquire Australian digital health operator Eucalyptus in a transaction valued at up to $1.15 billion. The deal is part of Hims & Hers' push to broaden its personalized care business into new international markets.
According to the announcement, the acquisition would provide Hims & Hers with a direct presence in Australia and Japan while also bolstering its footprint in the United Kingdom, Germany and Canada through partnerships with established regional operators. Eucalyptus runs several consumer-facing brands, including the weight-loss program Juniper and the men's telehealth brand Pilot, and Hims & Hers said the business has served more than 775,000 customers.
Financial terms disclosed include approximately $240 million payable in cash at the time the transaction closes. The company said the acquisition is expected to close during the middle of calendar year 2026.
The announcement comes as Hims & Hers faces a legal dispute with Novo Nordisk. The suit follows regulatory action by the U.S. Food and Drug Administration that led Hims & Hers to abruptly withdraw a newly launched $49 copy of Novo Nordisk's weight-loss drug Wegovy. Hims & Hers flagged the lawsuit as part of the same public disclosure that detailed the planned acquisition.
For Hims & Hers, acquiring Eucalyptus appears aimed at accelerating access to international consumers via existing digital brands and operator partnerships. Eucalyptus' consumer programs and telehealth offerings represent products and channels that Hims & Hers said will complement its personalized care strategy in markets outside the United States.
The timetable and structure described in the announcement leave open the usual uncertainties associated with closing large cross-border deals. The company identified the mid-2026 closing window and the initial cash component, but did not elaborate further on the transaction mechanics in the disclosure.
Contextual note - The acquisition announcement ties together Hims & Hers' international expansion plans and the immediate legal and regulatory challenges it has disclosed. The company reported the customer count for Eucalyptus and specified brands that will transfer to Hims & Hers upon completion of the deal.